Zami Aberman
2020
In 2020, Zami Aberman earned a total compensation of $501.2K as Executive Chairman at Pluristem Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Salary | $439,704 |
|---|---|
| Other | $61,540 |
| Total | $501,244 |
Aberman received $439.7K in salary, accounting for 88% of the total pay in 2020.
Aberman also received $61.5K in other compensation.
Rankings
In 2020, Zami Aberman's compensation ranked 11,021st out of 13,090 executives tracked by ExecPay. In other words, Aberman earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,021 out of 13,090 | 16th |
Division Manufacturing | 4,708 out of 5,621 | 16th |
Major group Chemicals And Allied Products | 1,958 out of 2,254 | 13th |
Industry group Drugs | 1,712 out of 1,954 | 12th |
Industry Biological Products, Except Diagnostic Substances | 383 out of 411 | 7th |
Source: SEC filing on April 8, 2021.
Aberman's colleagues
We found two more compensation records of executives who worked with Zami Aberman at Pluristem Therapeutics in 2020.
News
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019